CFAO Healthcare has acquired Medimport, a leading pharmaceutical distributor in Mozambique, to strengthen its expansion in Lusophone Africa and enhance access to quality medicines.

Information on the Target

Medimport is one of the premier pharmaceutical distributors in Mozambique, recognized for its extensive distribution network and reliable supply of pharmaceutical products across the country. The company has established itself as a vital player in the healthcare sector, facilitating access to essential medicines and contributing to the overall improvement of health outcomes in the region.

By acquiring Medimport, CFAO Healthcare is poised to leverage its established reputation and distribution capabilities to enhance the quality and availability of healthcare products in Mozambique. This acquisition not only aligns with CFAO’s mission to provide high-quality healthcare solutions but also supports the country's growing demand for reliable pharmaceutical supply chains.

Industry Overview in Mozambique

The pharmaceutical industry in Mozambique has been evolving steadily, driven by increased healthcare demands and a growing population. The government has taken significant steps to improve healthcare in

View Source

Similar Deals

Medibank Better Medical

2026

Other Hospitals, Clinics & Primary Care Services Australia
Abbott Exact Sciences

2026

Other In-Vivo Diagnostic & Testing Substances United States of America
ルネサンス マイリハ

2026

Other Residential & Long-Term Care Japan
Edwards Lifesciences JenaValve Technology

2026

Other Medical Devices & Implants United States of America

CFAO Healthcare

invested in

Medimport

in 2024

in a Other deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert